Cargando…
Clinical and immunological correlates of long term survival in glioblastoma
Glioblastoma (GBM) is the most common and most aggressive type of primary brain tumour in adults. It represents 54% of all gliomas and 16% of all brain tumours (Ostrom et al. 2016). Despite surgery and treatment with radiotherapy plus an oral alkylating agent, temozolomide (TMZ), tumours invariably...
Autores principales: | Czapski, Bartosz, Baluszek, Szymon, Herold-Mende, Christel, Kaminska, Bozena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885076/ https://www.ncbi.nlm.nih.gov/pubmed/29628799 http://dx.doi.org/10.5114/wo.2018.73893 |
Ejemplares similares
-
Supportive roles of brain macrophages in CNS metastases and assessment of new approaches targeting their functions
por: You, Hua, et al.
Publicado: (2020) -
Immune Microenvironment of Brain Metastases—Are Microglia and Other Brain Macrophages Little Helpers?
por: You, Hua, et al.
Publicado: (2019) -
Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
por: Kaminska, Bozena, et al.
Publicado: (2019) -
Long-term survival outcomes of pineal region gliomas
por: Choque-Velasquez, Joham, et al.
Publicado: (2020) -
CD133/prominin1 is prognostic for GBM patient’s survival, but inversely correlated with cysteine cathepsins’ expression in glioblastoma derived spheroids
por: Ardebili, Seyed Y., et al.
Publicado: (2011)